FindMyKOL
Clinical trialNCT00933088TerminatedObservational

Adolescent Daughters' Response and Adjustment to Maternal Breast Cancer

NCT00933088 is an observational study sponsored by NYU Langone Health. As of 21 Nov 2026, it was terminated. It studies Breast Cancer. The registry lists an enrollment of 43 participants at 2 sites in 1 country. The registry lists a start date of 30 Jun 2008 and a primary completion date of 31 Oct 2009.

SponsorNYU Langone Health →Enrollment43Breast Cancer
View the registry record on ClinicalTrials.gov

Key facts

Registry attributes as recorded on the ClinicalTrials.gov study record.

Key facts for NCT00933088
FieldValue
Registry IDNCT00933088
StatusTerminated
Study typeObservational study
Lead sponsorNYU Langone Health
Enrollment43
Registered sites2
Countries1
ConditionsBreast Cancer
Start30 Jun 2008
Primary completion31 Oct 2009
Study completion31 Oct 2009
Last update posted24 Jun 2016

Registered summary

The lay summary the sponsor registered on ClinicalTrials.gov.

The aims of this study are to determine the differential coping strategies used by adolescent daughters whose mothers have breast cancer, and how this relates to the stress responses they exhibit.

Investigators

The overall officials registered on this study. Names that resolve to a FindMyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

2 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

New York, United States2 sites
  • Bellevue Hospital Center

    New York

  • New York University Cancer Center

    New York

United States, by state

AlaskaAKMaineMEVermontVTNew HampshireNHWashingtonWAMontanaMTNorth DakotaNDMinnesotaMNWisconsinWIMichiganMINew York: 2 sitesNY2MassachusettsMARhode IslandRIOregonORIdahoIDSouth DakotaSDIowaIAIllinoisILIndianaINOhioOHPennsylvaniaPANew JerseyNJConnecticutCTCaliforniaCANevadaNVWyomingWYNebraskaNEMissouriMOKentuckyKYWest VirginiaWVVirginiaVAMarylandMDDelawareDEArizonaAZUtahUTColoradoCOKansasKSArkansasARTennesseeTNNorth CarolinaNCSouth CarolinaSCNew MexicoNMOklahomaOKLouisianaLAMississippiMSAlabamaALGeorgiaGAHawaiiHITexasTXFloridaFLDistrict of ColumbiaDC
Fewer sitesMore sites

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study. It may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Questions about NCT00933088

Each answer restates registry values shown on this page.

What is NCT00933088?

NCT00933088 is an observational study sponsored by NYU Langone Health. It studies Breast Cancer.

Who leads NCT00933088?

The registry names Yelena Novik, MD (principal investigator, NYU Langone Health) as the overall official.

Where does NCT00933088 run?

The registry lists 2 sites in 1 country. Every site with a stated country is in one country: United States.

When did NCT00933088 end?

The registry lists a primary completion date of 31 Oct 2009 and a study completion date of 31 Oct 2009. The sponsor last updated the record on 24 Jun 2016.

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 21 Nov 2026. Registry facts are shown as registered by the study sponsor; FindMyKOL does not interpret them.